Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 37 citations · 27 references
Life SciencesBiochemistryMolecular BiologyCell SignalingChemotherapySignal TransductionCoagulation AbnormalitiesEndothelial Regulation Of HemostasisThrombosisThrombosis PreventionEndothelial Contribution To ThrombosisEndothelial Protein C PathwayEndothelial Regulation Of CoagulationNf-κb SignalingProteasome Inhibitor TherapyProteasome InhibitorsSystemic AdministrationThrombosis Mechanisms
OBJECTIVE: Impairment of the thrombomodulin-protein C anticoagulant pathway has been implicated in pathological thrombosis associated with malignancy. Patients who receive proteasome inhibitors as part of their chemotherapeutic regimen appear to be at decreased risk for thromboembolic events. We investigated the effects of proteasome inhibitors on endothelial thrombomodulin expression and function. METHODS AND RESULTS: Proteasome inhibitors as a class markedly induced the expression of thrombomodulin and enhanced the protein C activating capacity of endothelial cells. Thrombomodulin upregulation was independent of NF-kappaB signaling, a principal target of proteasome inhibitors, but was instead a direct consequence of increased expression of the Krüppel-like transcription factors, KLF2 and KLF4. These effects were confirmed in vivo, where systemic administration of a proteasome inhibitor enhanced thrombomodulin expression that was paralleled by changes in the expression of KLF2 and KLF4. CONCLUSIONS: These findings identify a novel mechanism of action of proteasome inhibitors that may help to explain their clinically observed thromboprotective effects.
27
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
Jeanet W. Blom · JAMA · 2005 · 2K citations
Medicine, Genetics, Hematology +14
<i>KLF6</i> , a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer
Goutham Narla, Karen E. Heath, Helen L. Reeves et al. · Science · 2001 · 451 citations